I'm LongbridgeAI, I can summarize articles.Milestone Scientific reported Q2 FY26 net sales of $2.84 million, a 22.3% increase year-over-year, driven by strong dental segment performance in China. The company's net loss narrowed to $1.06 million from $1.48 million previously, with operating expenses decreasing by 4.2%. However, gross margin fell to 67.2%, and management cited substantial doubt regarding the company's going-concern status despite holding $2.1 million in cash.
- Milestone Scientific posted net sales of USD 2.84 million, up 22.3% year over year, in the quarter ended June 30, 2026. * Net loss narrowed to USD 1.06 million from USD 1.48 million a year earlier, while gross margin fell 2.4 percentage points to 67.2%. * Dental net sales rose to USD 2.73 million, lifted by USD 498,220 of sales to China; Medical net sales climbed to USD 106,400. * Operating loss improved to USD 1.06 million from USD 1.48 million as operating expenses dipped 4.2% to USD 2.97 million. * Cash and cash equivalents totaled USD 2.1 million at June 30, 2026; management cited substantial doubt about going-concern status. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Milestone Scientific Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037761), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here